Cryptococcosis classification: Difference between revisions

Jump to navigation Jump to search
Line 10: Line 10:
===Site of Infection===
===Site of Infection===
*'''Pulmonary Cryptococcosis'''
*'''Pulmonary Cryptococcosis'''
:*
:*The most common clinical syndrome associated with Cryptococcus.
:*Related to the mode of transmission via aerosolized basidiospores.
:*Extra-pulmonary infections are thought to be secondary to a primary pulmonary infection even in cases where the latter is not evident.
*'''Central Nervous System (CNS) Cryptococcosis'''
*'''Central Nervous System (CNS) Cryptococcosis'''
:*
:*Classically seen in patients with AIDS and low CD4 counts (below 100).
:*Secondary to dissemination of inhaled spores in patients who are severely immunocompromised.
:*Cryptococcosis is the number one cause of meningitis in adults.
*'''Disseminated Cryptococcosis'''
*'''Disseminated Cryptococcosis'''
:*
:*Most often involves the skin, soft tissue, and the medulla of the bone in addition to the lungs and CNS.
:*Also associated with a severely immunocompromised status.
 
===Causative Species or Variety===
===Causative Species or Variety===
*'''''Cryptococcus neoformans'''''
*'''''Cryptococcus neoformans'''''

Revision as of 14:45, 11 January 2016

Cryptococcosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cryptococcosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cryptococcosis classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cryptococcosis classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cryptococcosis classification

CDC on Cryptococcosis classification

Cryptococcosis classification in the news

Blogs on Cryptococcosis classification

Directions to Hospitals Treating Cryptococcosis

Risk calculators and risk factors for Cryptococcosis classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Serge Korjian M.D.; Yazan Daaboul, M.D.

Overview

Classification

Cryptococcosis may be classified based on the site of infection i.e. the clinical syndrome, or the species or variety of the cryptococcus causative organism.

Site of Infection

  • Pulmonary Cryptococcosis
  • The most common clinical syndrome associated with Cryptococcus.
  • Related to the mode of transmission via aerosolized basidiospores.
  • Extra-pulmonary infections are thought to be secondary to a primary pulmonary infection even in cases where the latter is not evident.
  • Central Nervous System (CNS) Cryptococcosis
  • Classically seen in patients with AIDS and low CD4 counts (below 100).
  • Secondary to dissemination of inhaled spores in patients who are severely immunocompromised.
  • Cryptococcosis is the number one cause of meningitis in adults.
  • Disseminated Cryptococcosis
  • Most often involves the skin, soft tissue, and the medulla of the bone in addition to the lungs and CNS.
  • Also associated with a severely immunocompromised status.

Causative Species or Variety

  • Cryptococcus neoformans
  • Cryptococcus neoformans v. neoformans
  • Cryptococcus neoformans v. grubii
  • Cryptococcus gattii
  • Cryptococcus uniguttulatus
  • Cryptococcus laurentii
  • Cryptococcus albidus
  • Although other species of cryptococci exist, they are not known to be infectious to humans.

References